HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiro Yoshikawa Selected Research

Interferon-alpha (Interferon Alfa)

9/2009Low expression of microphthalmia-associated transcription factor, a potential molecular target for interferon-alpha susceptibility, is associated with metastasis in renal cell carcinoma.
4/2007Prediction of in vitro response to interferon-alpha in renal cell carcinoma cell lines.
4/2006Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiro Yoshikawa Research Topics

Disease

42Neoplasms (Cancer)
05/2024 - 10/2002
10Renal Cell Carcinoma (Grawitz Tumor)
02/2022 - 09/2003
10Prostatic Neoplasms (Prostate Cancer)
08/2021 - 04/2004
7Squamous Cell Carcinoma of Head and Neck
05/2024 - 05/2011
5Moyamoya Disease (Moya-Moya Disease)
01/2023 - 11/2010
5Neoplasm Metastasis (Metastasis)
01/2019 - 09/2004
3Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2024 - 11/2017
3Proteinuria
11/2022 - 01/2018
3Leukemia
05/2021 - 12/2004
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 10/2002
3Glioma (Gliomas)
12/2010 - 02/2003
2Infections
02/2024 - 01/2006
2Chronic Kidney Failure (Chronic Renal Failure)
11/2023 - 01/2011
2Head and Neck Neoplasms (Head and Neck Cancer)
08/2023 - 11/2017
2Disease Progression
01/2023 - 10/2022
2Inflammation (Inflammations)
12/2022 - 11/2013
2Macular Edema
11/2022 - 10/2022
2Thrombotic Microangiopathies
11/2022 - 10/2022
2Hypertension (High Blood Pressure)
10/2022 - 01/2018
2Nephrotic Syndrome (Syndrome, Nephrotic)
10/2022 - 01/2018
2Mouth Neoplasms (Oral Cancer)
09/2022 - 05/2011
2Edema (Dropsy)
01/2018 - 07/2017
2Adenocarcinoma
01/2015 - 10/2008
2Lymphoma (Lymphomas)
02/2013 - 12/2004
2Glioblastoma (Glioblastoma Multiforme)
12/2010 - 06/2008
2Brain Neoplasms (Brain Tumor)
06/2008 - 09/2005
2Sepsis (Septicemia)
01/2008 - 01/2006
1Hypoxia (Hypoxemia)
02/2024
1Acidosis
02/2024
1Peritonitis
02/2024
1Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2023
1MYH9-Related Disorders
03/2023
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
03/2023
1Mucoepidermoid Carcinoma
01/2023
1Fibrosis (Cirrhosis)
12/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2022
1Diabetes Mellitus
10/2022
1Macular Degeneration (Age-Related Maculopathy)
10/2022

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
12/2020 - 04/2006
8Peptides (Polypeptides)IBA
01/2019 - 09/2003
7AntigensIBA
05/2024 - 09/2003
5Biomarkers (Surrogate Marker)IBA
06/2023 - 07/2009
4Immune Checkpoint InhibitorsIBA
02/2024 - 03/2016
4Cisplatin (Platino)FDA LinkGeneric
08/2023 - 11/2017
4Immunoglobulin G (IgG)IBA
12/2022 - 03/2006
4AntibodiesIBA
02/2022 - 07/2005
4Messenger RNA (mRNA)IBA
10/2021 - 10/2003
4Androgen Receptors (Androgen Receptor)IBA
08/2021 - 09/2014
3Fluorouracil (Carac)FDA LinkGeneric
01/2023 - 11/2017
3Monoclonal AntibodiesIBA
03/2016 - 07/2003
3Wr-T peptideIBA
02/2013 - 06/2008
3Cyclin-Dependent Kinase Inhibitor p16IBA
02/2013 - 12/2004
3Interferon-alpha (Interferon Alfa)IBA
09/2009 - 04/2006
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2024 - 12/2010
2Carbonic Anhydrase IXIBA
02/2024 - 05/2011
2EnzymesIBA
02/2024 - 03/2007
2afliberceptIBA
11/2022 - 10/2022
2Hormones (Hormone)IBA
10/2019 - 07/2019
2Retinoblastoma ProteinIBA
01/2019 - 02/2013
2TensinsIBA
11/2018 - 01/2015
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2018 - 01/2015
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2018 - 01/2013
2Dacarbazine (DIC)FDA LinkGeneric
03/2016 - 01/2008
2AndrogensIBA
01/2015 - 09/2014
2Therapeutic UsesIBA
09/2014 - 11/2013
2epidermal growth factor receptor VIIIIBA
12/2010 - 07/2003
2ErbB Receptors (EGF Receptor)IBA
12/2010 - 07/2003
2Microphthalmia-Associated Transcription FactorIBA
09/2009 - 04/2007
2K cadherinIBA
09/2004 - 10/2003
1Small Interfering RNA (siRNA)IBA
02/2024
1IronIBA
08/2023
1artemisinin (artemisinine)IBA
08/2023
1ArtesunateIBA
08/2023
12- (2- (3,4- dihydroxy- 5- (hydroxymethyl)oxolan- 2- yl)- 1- methylcarbamimidamido)acetic acidIBA
06/2023
1Immunoglobulin A (IgA)IBA
03/2023
1Cetuximab (Erbitux)FDA Link
01/2023
1Long Noncoding RNAIBA
01/2023
1MicroRNAs (MicroRNA)IBA
01/2023
1trametinibIBA
12/2022
1mogamulizumabIBA
12/2022
1Interleukin-6 (Interleukin 6)IBA
12/2022
1SaltsIBA
12/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022
1Granzymes (Granzyme)IBA
09/2022
1PerforinIBA
09/2022
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
02/2022
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022
1Axitinib (AG 013736)IBA
02/2022

Therapy/Procedure

22Therapeutics
02/2024 - 12/2004
10Immunotherapy
09/2022 - 05/2008
6Castration
08/2021 - 09/2014
3Catheters
02/2024 - 07/2017
2Intravitreal Injections
11/2022 - 10/2022
2Drug Therapy (Chemotherapy)
11/2017 - 11/2014
2Aftercare (After-Treatment)
03/2016 - 10/2002
2Chemoprevention
05/2015 - 01/2015
2Lasers (Laser)
01/2015 - 07/2009
2Renal Dialysis (Hemodialysis)
12/2013 - 01/2011
1Kidney Transplantation
11/2023